ArticleScientific reports2017

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.

Ilze Bot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.